Genetron Health Reports Unaudited Second Quarter 2022 Financial Results

October 12, 2022

https://www.globenewswire.com/news-release/2022/10/12/2532613/0/en/Genetron-Health-Reports-Unaudited-Second-Quarter-2022-Financial-Results.html

BEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today reported its unaudited financial results for the second quarter ended June 30, 2022.

Read more at globenewswire.com

Related news for (GTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.